No recent news or business developments have been reported for Byrn, Inc. The company remains a dormant shell with no disclosed active operations.

The company has undergone significant restructuring and ownership changes, which could provide a foundation for future strategic initiatives. The appointment of new management in 2026 may indicate potential for reactivation or repositioning of the company. Historical focus on healthcare analytics and digital retail solutions suggests prior domain expertise that could be leveraged if operations resume.

Byrn, Inc. has been dormant for extended periods, with no recent revenue or cash reserves and significant current liabilities exceeding current assets. The voided share exchange and multiple custodianships indicate operational and financial instability. The lack of disclosed active business operations and ongoing net losses highlight substantial challenges to business viability.

Byrn, Inc. does not currently operate an active business and is classified as a dormant shell company. There is no disclosed competitive advantage or moat in the available filings. Historical operations focused on healthcare software and digital retail solutions, but no ongoing operations or proprietary assets are reported.

• Liquidity Risk: As of March 31, 2026, Byrn had no cash or cash equivalents and a current ratio of 0.06, indicating significant liquidity constraints to meet short-term obligations.
• Operational Dormancy: The company has been dormant for multiple extended periods, including from 2013 to 2019 and again from 2021 through mid-2023, with no disclosed active business operations.
• Ownership and Management Changes: Frequent changes in ownership and management, including custodianship and resignation of key officers, may impact strategic continuity and operational execution.
• Lack of Revenue and Profitability: The latest financials show a net loss and no reported revenue in recent periods, reflecting ongoing financial challenges.

• Byrn, Inc. is a Nevada corporation formed in April 2011 originally as Quture International, Inc.
• The company was created as an emerging healthcare knowledge solution company focused on medical software tools and analytics to improve clinical performance and outcomes.
• From March 2013 through December 2019, the company was dormant.
• In late 2019, Custodian Ventures, LLC was appointed custodian and David Lazar became sole director and officer.
• In 2020, the company issued preferred shares with super-voting rights convertible into common stock.
• A controlling shareholder acquired approximately 50.2% voting rights in 2020, and the original director/officer resigned.
• The company underwent a reverse stock split and name changes from Quture International, Inc. to Born, Inc., and later to Byrn, Inc. in July 2024.
• A share exchange agreement with Alkeon Creators, Inc. in February 2021 was voided, resulting in the company being a dormant shell from February 2021 through July 2023.
• Byrn was a holding company specializing in digital, data-led solutions for retail supply chains and online transactions before dormancy.
• As of March 31, 2026, the company had no cash or cash equivalents, current assets of $2,178, and current liabilities of $36,440, resulting in a current ratio of 0.06 and a cash ratio of 0.
• The company reported a net loss of $30,937 for the quarter ended March 31, 2026, with zero basic and diluted earnings per share.
• There are no pending legal proceedings involving the company or its affiliates.
• The company is classified as a smaller reporting company and is not required to disclose risk factors.
• Management changes occurred in April 2026 with David Lazar resigning and John Leo appointed as sole director and CEO, and Arthur Magee as CFO and Secretary.